CLYM116 Shows Durable APRIL Suppression
Climb Bio reported initial Phase I healthy-volunteer data for CLYM116, a pH-dependent APRIL “sweeper” antibody licensed from Beijing Mabworks. A single 320-mg subcutaneous dose produced greater than 90% free-APRIL suppression through week 10 and…
